{
  "retracted": false,
  "timestamp": 1522540800000,
  "updates": [
    {
      "timestamp": 1585541136272,
      "identifier": {
        "doi": "10.1161/hcq.0000000000000038"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1161/circoutcomes.118.004665"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Correction to: Moving the Goalposts Into Unblinded Territory: The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA [‘Faith Healing’ and ‘Subtraction Anxiety’ in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial]"
}
